GSK plcGSKNYSE
Loading
ROE: Strong ReturnsExpanding
Percentile Rank21
3Y CAGR-37.2%
5Y CAGR-2.4%
Year-over-Year Change
Return on equity
3Y CAGR
-37.2%/yr
vs +14.2%/yr prior
5Y CAGR
-2.4%/yr
Recent deceleration
Acceleration
-51.4pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 34.90% | +85.3% |
| 2024 | 18.84% | -49.0% |
| 2023 | 36.92% | -73.8% |
| 2022 | 141.12% | +384.5% |
| 2021 | 29.13% | -26.1% |
| 2020 | 39.41% | +1.7% |
| 2019 | 38.76% | -53.4% |
| 2018 | 83.10% | +103.7% |
| 2017 | -2252.94% | -2876.7% |
| 2016 | 81.14% | - |